The five entities include three pharmaceutical companies — drug major Cipla, FDC and Macleods Pharmaceuticals — as well as the Himachal Pradesh Society of Chemists & Druggist Alliance and its president Sanjeev Pandit.
The move has been triggered by a complaint from Rohit Medical store, alleging anti-competitive practices by the five entities in granting stockist licence for medicines in Himachal Pradesh.
Also Read
After examining the complaint, the regulator observed that the Himachal Pradesh Society of Chemist & Druggist Alliance appears to be controlling and regulating the appointment of stockist-ship of each and every pharmaceutical company in the state. “The evidence placed on record by the informant shows that no one can be appointed as the stockist of any pharmaceutical company in the state of Himachal Pradesh without the No Objection Certificate (NOC) of Opposite Party No. 5 (Himachal Pradesh Society of Chemist & Druggist Alliance) association,” the CCI order said.
It further said that from examination of facts and circumstances, it appears that the conduct of the association in making it compulsory for the complainant to obtain a NOC before appointment as stockist of the three pharma companies, is in violation of the Competition Act.
The complaint alleged that it was not being granted stockist-ship of Macleods Pharmaceutical, FDC and Cipla due to the condition imposed to obtain a NOC from the chemists association.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)